BACKGROUND: Cancer patients are encouraged to obtain second opinions before starting treatment. Little is known about men with localized prostate cancer who seek second opinions, the reasons why, and the association with treatment and quality of care. METHODS: We surveyed men who were diagnosed with localized prostate cancer in the greater Philadelphia area from 2012 to 2014. Men were asked if they obtained a second opinion from a urologist, and the reasons why. We used multivariable logistic regression models to evaluate the relationship between second opinions and definitive prostate cancer treatment and perceived quality of care. RESULTS: A total of 2386 men responded to the survey (adjusted response rate, 51.1%). After applying exclusion criteria, the final analytic cohort included 2365 respondents. Of these, 40% obtained second opinions, most commonly because they wanted more information about their cancer (50.8%) and wanted to be seen by the best doctor (46.3%). Overall, obtaining second opinions was not associated with definitive treatment or perceived quality of cancer care. Men who sought second opinions because they were dissatisfied with their initial urologist were less likely to receive definitive treatment (odds ratio, 0.49; 95% confidence interval, 0.32-0.73), and men who wanted more information about treatment were less likely to report excellent quality of cancer care (odds ratio, 0.70; 95% confidence interval, 0.49-0.99) compared with men who did not receive a second opinion. CONCLUSIONS: Although a large proportion of men with localized prostate cancer obtained a second opinion, the reasons for doing so were not associated with treatment choice or perceived quality of cancer care. Future study is needed to determine when second opinions contribute to increasing the value of cancer care. Cancer 2017;123:1027-34. V C 2016 American Cancer Society.
INTRODUCTION
The National Cancer Institute and the American Cancer Society encourage patients with cancer to obtain second opinions before starting treatment. 1 With increasing options for cancer treatment, patients need to weigh risks and benefits and consider how each choice aligns with their personal preferences. Second opinions may be helpful by enabling patients to gather more information about their cancer diagnosis, hear about potential management plans, and better understand their disease. [2] [3] [4] However, relatively little is known about who seeks second opinions, the reasons why, and their impact on treatment choices and experiences of care.
In a recent systematic review, Ruetters et al. 5 identified 13 studies examining second opinions among cancer patients. Many of the published studies focused on women with breast cancer, had small sample sizes, frequently lacked racial, ethnic, and socioeconomic diversity, and often represented only single institutions. In the reviewed studies, 6.5% to 36% of cancer patients obtained a second opinion. The most common reasons for obtaining a second opinion included dissatisfaction with an initial physician, a desire for more information before making a treatment decision, and a desire for confirmatory advice about their diagnosis and treatment recommendation. Previous studies have shown that second opinions may be linked with patient experience with cancer care; patients report a higher level of satisfaction with physician communication during the second opinion visit, however, there is no association with perceived quality of care.
Second opinions in the setting of prostate cancer may be uniquely important for several reasons. First, prostate cancer is a substantial public health burden, with an estimated 180,890 men diagnosed in 2016. 8 Second, treatment options for localized prostate cancer vary widely from surgery and radiation therapy to active surveillance programs with differing benefits and costs. [9] [10] [11] Second opinions could provide patients with more information about their treatment options. 5 Third, research using claims data suggests that nearly 40% of men with prostate cancer have different diagnosing and treating urologists. 12 Although these data may suggest that men frequently obtain second opinions, studies examining the prevalence of second opinions among this population are limited. Finally, urologists providing a second opinion are more likely to recommend radical prostatectomy, potentially increasing the influence of second opinions on treatment. 13 In this study, we assessed the frequency and reasons for second opinions for localized prostate cancer and the characteristics of the patients who seek them. We also assessed whether second opinions are associated with treatment choice and perceived quality of prostate cancer care. Based on previous studies, we hypothesized that patients who obtain a second opinion are more likely to receive definitive treatment but report similar quality of care compared with patients who did not.
METHODS
The data for our analysis were obtained from the Philadelphia Area Prostate Cancer Access Study (P 2 Access), a cohort study of black and white men with newly diagnosed localized prostate cancer from the greater Philadelphia area. The Institutional Review Boards of the University of Pennsylvania and Johns Hopkins University approved this study.
Patient Population and Recruitment
Men were identified from the Pennsylvania Cancer Registry (PCR) and were eligible to participate if they were diagnosed with localized prostate cancer between January 1, 2012, and December 31, 2014, and were a resident of the greater Philadelphia region (which was defined as Berks, Bucks, Chester, Delaware, Lancaster, Lehigh, Montgomery, and Philadelphia counties). Participants were excluded if they had military insurance or received chemotherapy for treatment. For our analytic cohort, we also excluded men who did not see a urologist for an initial consultation, given that the study focused on men who obtained second opinions from urologists (99% of men reported having an initial visit with a urologist).
A total of 4676 eligible men were mailed surveys between February 2014 and August 2015 (see online supporting information). An unconditional $2 incentive was provided with the first mailing. Nonresponders were also sent an additional mailing of the survey and received follow-up phone calls. Participants received $15 upon completion of the survey.
Measures

Second opinions
To determine whether men obtained second opinions from another urologist, we asked: "Did you get an opinion from more than 1 urologist about your prostate cancer? In other words, did you get a second opinion?" If they answered yes, they were further asked to choose 1 or more of the following reasons for obtaining second opinions: 1) wanted more information about cancer; 2) dissatisfaction with initial doctor; 3) wanted the best doctor; 4) wanted information about treatment options not offered by initial doctor; 5) encouraged by family and friends; and 6) other. These reasons were selected based on previous studies and were pilot tested within a similar cohort of men newly diagnosed with localized prostate cancer.
1, 3, 6 Outcome measures
We determined whether a patient had received definitive treatment defined as either radical prostatectomy or radiation therapy (external beam radiation therapy or seed brachytherapy) from the PCR. We measured perceived quality of prostate cancer care in the survey by asking men, "Overall, how would you rate the quality of health care for your prostate cancer?" with responses on a 5-point scale (dichotomized as excellent or not in our analyses).
Patient and tumor characteristics
Additional patient characteristics measured in the survey included age, race/ethnicity, education, and marital status. Insurance status at the time of diagnosis was obtained from the PCR. These factors have previously been shown to influence prostate cancer treatment.
14, 15 We calculated life expectancy using a validated mortality index using factors measured in the survey including: age, sex, body mass index, comorbidities, and functional limitations. 16 We obtained tumor characteristics (tumor stage and Gleason score) from the PCR. Men were also asked if they had seen a radiation oncologist in the course of choosing their Original Article treatment for prostate cancer as specialist referral has been shown to influence treatment choice.
17,18
Statistical analysis
We summarized the characteristics of respondents along with their reasons for obtaining a second opinion. Using a chi-squared test, we compared the socio-demographic factors (age, race/ethnicity, education, insurance, and marital status), clinical characteristics (Gleason score, clinical tumor stage, life expectancy), and consultation with another specialist (consultation with a radiation oncologist) of men who did and did not obtain a second opinion from a urologist. Using multivariable logistic regression, we investigated patient and tumor characteristics independently associated with obtaining a second opinion. We then modeled the association of obtaining a second opinion with 3 outcomes using multivariable logistic regression: 1) receipt of definitive treatment; 2) receipt of surgery among men who received definitive treatment; and 3) perceived quality of prostate cancer care. As a secondary analysis, we examined the characteristics of men that sought second opinions for specific reasons (e.g., wanted more information about cancer) and the association of those second opinions with treatment choice and perceived quality of prostate cancer care. Separate models were run for each reason for obtaining a second opinion. Finally, we examined the association between second opinions and receipt of definitive treatment and receipt of surgery among men who received definitive treatment among men with lowrisk prostate cancer (defined based on National Comprehensive Cancer Network classification).
To account for missing data in our model covariates, we used multiple imputation methods. Using multiple chained equations and performing 5 imputations, we imputed all covariates except for our primary independent variable (obtaining a second opinion) and our outcome variables (receipt of definitive treatment, type of treatment, and perceived quality of prostate cancer care).
19 All analyses were performed using Stata version 13.0 (StataCorp, College Station, TX).
RESULTS
Of the 4676 eligible men, 2386 responded to the survey for an adjusted response rate of 51.1%. After applying exclusion criteria, the final analytic cohort included 2365 respondents. Responders were more likely to be white (77.5% vs 61.5%), have private insurance (54.9% vs 50.9%), and receive definitive treatment (79.5% vs 70.9%) compared with nonresponders (Supporting Table  1 ). The average age of men who responded was 65.4 years (standard deviation, 8.4 years) ( Table 1 ). The majority were white (78.5%), educated (62.2% with some college education or higher), and privately insured (55.3%). Most men had lower-risk tumors with Gleason scores 7 (79.6%) and clinical tumor stage I disease (71.4%).
Frequency and Reasons for Second Opinions
A substantial proportion of men (40.2%) obtained a second opinion from a urologist; of these, over half (51.2%) reported more than 1 reason. The most common reasons cited for obtaining second opinions from urologists included wanting more information about their cancer (50.8%) and wanting to be seen by the best doctor (46.3%) ( Figure  1 ). Thirty-one percent of patients indicated they were encouraged by a family member or friend to obtain a second opinion, and 25% noted that they wanted to find out about treatment not offered by their first doctor. Dissatisfaction with their initial urologist was the least frequently reported reason to seek a second opinion (15.5%). Table 1 ). However, patients aged 75 years were least likely to report obtaining a second opinion due to dissatisfaction with their initial urologist. Men with a college education or higher also were more likely to cite wanting more information about their cancer as a motivation for a second opinion (Supporting Table 2 ).
Association of Second Opinions with Treatment and Perceived Quality of Care
Overall, nearly 80% of men received definitive treatment; 76.5% of men who obtained a second opinion from a urologist received definitive treatment compared with 81.6% who did not (P 5 .04). In adjusted models, obtaining a second opinion was not associated with receipt of definitive treatment (OR, 0.95; 95% CI, 0.84-1.08; Table  3 ). Similarly, among those who received definitive treatment, second opinions were not associated with receiving surgery. Furthermore, among men with low-risk disease, we did not observe a significant association between second opinions and receipt of definitive treatment or surgery. Receiving a second opinion was not associated with perceived quality of prostate cancer care. Although they constituted a modest fraction of the sample, men who obtained a second opinion because they were dissatisfied with their initial doctor were less likely to receive definitive treatment compared with men who did not receive a second opinion (OR, 0.49; 95% CI, 0.32-0.73). Among men who received definitive treatment, those who obtained second opinions because they wanted Original Article more information about their cancer (OR, 1.70; 95% CI, 1.24-2.34), wanted the best doctor (OR, 2.46; 95% CI, 1.72-3.51), or were encouraged by friends/family (OR, 2.25; 95% CI, 1.49-3.39) were more likely to receive surgery compared with men who did not receive a second opinion. Men who sought second opinions because they wanted information about treatment not offered by their initial urologist were less likely to report excellent quality of prostate cancer care (OR, 0.70; 95% CI, 0.49-0.99).
DISCUSSION
In a large cohort of men with localized prostate cancer, 40% reported obtaining second opinions from urologists, most commonly because they wanted more information about their cancer and wanted to be seen by the best doctor. However, obtaining a second opinion was not associated with definitive treatment choice. National organizations encourage patients to seek second opinions to promote preference-sensitive treatment decisions-a uniquely important concern for localized prostate cancer, where overtreatment is common. It is noteworthy that certain motivations for seeking second opinions-wanting more information, wanting the best doctor, or receiving encouragement from friends/family-were actually associated with higher rates of surgery. Our results suggest that second opinions may be common in prostate cancer; however, the extent to which they promote delivery of high-value care remains less clear. The proportion of men in our study that obtained a second opinion was similar to that described by DuGoff et al 12 in a study of men with prostate cancer, but higher than rates have been reported in other types of cancer. 6, 20 The high rate of seeking second opinions for localized prostate cancer may reflect the complexity of decisionmaking for treatment with multiple different treatment modalities with varying risks and benefits. It may also reflect the less urgent nature of beginning treatment compared with other types of cancer. 21, 22 In contrast to other cancers, time to definitive treatment in localized prostate cancer has not been linked to better cancer control, potentially allowing men more time to seek second opinions. 23, 24 Although other studies involving cancer patients have found that patients commonly seek second opinions due to dissatisfaction with their physician, this was the least likely reason cited in our study. 5 These findings suggest that across different types of cancer, the motivations and context for seeking second opinions differ.
In a previous study, Tattersall et al 6 found that 42% of cancer patients (mostly women with breast cancer) who saw a medical oncologist for a second opinion changed their treatment plan. Our study extends this finding by examining the impact of second opinions from urologists on prostate cancer treatment choices. Although we did not observe an overall association of second opinions with treatment choice, the subgroup of men who pursued a second opinion because they wanted more information, wanted the best doctor, or were encouraged by friends or family were more likely to receive surgical treatment. It is possible that these men obtained second opinions because they wanted or were encouraged to have surgery and wanted the best doctor to perform it. In this context, second opinions may sometimes function as a way to carry out a planned treatment rather than as a way to explore treatment options. Furthermore, we did not observe an association between second opinions and treatment among men with low-risk disease, which may suggest that second opinions, in and of themselves, may be insufficient to reduce overtreatment among this group.
Even without altering treatment patterns at a cohort level, it is possible that second opinions remain important Boldface values are statistically significant (P <.05).
for aligning patient preferences with treatment choices. Similar to previous studies, we found that men with a lower level of education were less likely to receive a second opinion. 6, 13, 20 Seeking second opinions can be considered to reflect active engagement by the patient in their health care. The literature has shown that black men and men with a lower level of education tend to participate less in shared medical decision-making related to their treatment, and black men in particular are notably undertreated for their prostate cancer. 4, 20, 25 This difference by socioeconomic status raises important considerations about the equitable distribution of cancer care, and future studies aimed at better understanding medical information seeking behaviors and targeting unmet needs among men with lower levels of education should be considered.
Our study has several limitations. First, our measure of second opinions was based on self-report, which may be subject to recall and social desirability bias. However, in contrast to claims-based data, which may only assess patterns of care, our study allows patients to directly state whether they sought a second opinion and to indicate the underlying reasons why, Second, we do not have information on the content of the discussions during a second opinion visit. To better understand how second opinions may or may not influence treatment choice, examining the content of physician-patient discussions is important for future work. Third, white men and those that received definitive treatment were more likely to respond to our survey. Fourth, our perceived measure of quality is not specific to particular providers. Finally, although the survey respondents were recruited from a cancer registry of a large and diverse geographic area with nearly 5.3 million residents from urban and suburban locales, the findings may not be generalizable to other areas.
In accordance with recommendations from national cancer organizations, our results suggest that a substantial proportion of men with prostate cancer obtain an opinion from a second urologist regarding their treatment. The high rate of second opinions underscores their potential importance in cancer care delivery. At the same time, we did not observe an overall association between second opinions and either the receipt of definitive treatment or perceived quality. Additional research is needed to better understand the content of these second opinion visits in order to assess their value in cancer care.
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